BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8064827)

  • 1. Velocardiofacial syndrome and DiGeorge sequence.
    Shprintzen RJ
    J Med Genet; 1994 May; 31(5):423-4. PubMed ID: 8064827
    [No Abstract]   [Full Text] [Related]  

  • 2. CATCH 22.
    Hall JG
    J Med Genet; 1993 Oct; 30(10):801-2. PubMed ID: 8230153
    [No Abstract]   [Full Text] [Related]  

  • 3. [Microdeletion of 22q11, DiGeorge and velocardiofacial syndrome].
    Hjalgrim H; Hahnemann JM; Timshel S; Brøndum-Nielsen K
    Ugeskr Laeger; 2000 Jul; 162(31):4169-70. PubMed ID: 10962926
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic basis of DiGeorge and velocardiofacial syndromes.
    Driscoll DA
    Curr Opin Pediatr; 1994 Dec; 6(6):702-6. PubMed ID: 7849818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Philadelphia story: the 22q11.2 deletion: report on 250 patients.
    McDonald-McGinn DM; Kirschner R; Goldmuntz E; Sullivan K; Eicher P; Gerdes M; Moss E; Solot C; Wang P; Jacobs I; Handler S; Knightly C; Heher K; Wilson M; Ming JE; Grace K; Driscoll D; Pasquariello P; Randall P; Larossa D; Emanuel BS; Zackai EH
    Genet Couns; 1999; 10(1):11-24. PubMed ID: 10191425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Velo-cardio-facial syndrome associated with chromosome 22 deletions encompassing the DiGeorge locus.
    Scambler PJ; Kelly D; Lindsay E; Williamson R; Goldberg R; Shprintzen R; Wilson DI; Goodship JA; Cross IE; Burn J
    Lancet; 1992 May; 339(8802):1138-9. PubMed ID: 1349369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital heart defects in patients with DiGeorge/velocardiofacial syndrome and del22q11.
    Marino B; Digilio MC; Toscano A; Giannotti A; Dallapiccola B
    Genet Couns; 1999; 10(1):25-33. PubMed ID: 10191426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Williams syndrome cognitive profile also characterizes Velocardiofacial/DiGeorge syndrome.
    Bearden CE; Wang PP; Simon TJ
    Am J Med Genet; 2002 Aug; 114(6):689-92. PubMed ID: 12210289
    [No Abstract]   [Full Text] [Related]  

  • 9. Screening for celiac disease in patients with deletion 22q11.2 (DiGeorge/velo-cardio-facial syndrome).
    Digilio MC; Giannotti A; Castro M; Colistro F; Ferretti F; Marino B; Dallapiccola B
    Am J Med Genet A; 2003 Sep; 121A(3):286-8. PubMed ID: 12923874
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence of 22q11 microdeletions in DiGeorge and velocardiofacial syndromes: implications for genetic counselling and prenatal diagnosis.
    Driscoll DA; Salvin J; Sellinger B; Budarf ML; McDonald-McGinn DM; Zackai EH; Emanuel BS
    J Med Genet; 1993 Oct; 30(10):813-7. PubMed ID: 8230155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DiGeorge syndrome: part of CATCH 22.
    Wilson DI; Burn J; Scambler P; Goodship J
    J Med Genet; 1993 Oct; 30(10):852-6. PubMed ID: 8230162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CATCH 22 syndrome: report of 7 infants with follow-up data and review of the recent advancements in the genetic knowledge of the locus 22q11.
    Sergi C; Serpi M; Müller-Navia J; Schnabel PA; Hagl S; Otto HF; Ulmer HE
    Pathologica; 1999 Jun; 91(3):166-72. PubMed ID: 10536461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is the autosomal dominant Optiz GBBB syndrome part of the DiGeorge/velocardiofacial syndrome with deletions of chromosome area 22q11.2?
    Wulfsberg EA
    Am J Med Genet; 1996 Aug; 64(3):523-4. PubMed ID: 8862634
    [No Abstract]   [Full Text] [Related]  

  • 14. Selected papers and abstracts of the Velo-Cardio-Facial Syndrome (del22q11) Meeting. Strasbourg, September 5-6, 1998.
    Genet Couns; 1999; 10(1):1-115. PubMed ID: 10438198
    [No Abstract]   [Full Text] [Related]  

  • 15. Goosecoid-like sequences and the smallest region of deletion overlap in DiGeorge and velocardiofacial syndromes.
    Pragliola A; Jurecic V; Chau CK; Philip N; Baldini A
    Am J Hum Genet; 1997 Dec; 61(6):1456-9. PubMed ID: 9399910
    [No Abstract]   [Full Text] [Related]  

  • 16. Microdeletions of chromosomal region 22q11 in patients with congenital conotruncal cardiac defects.
    Goldmuntz E; Driscoll D; Budarf ML; Zackai EH; McDonald-McGinn DM; Biegel JA; Emanuel BS
    J Med Genet; 1993 Oct; 30(10):807-12. PubMed ID: 7901419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size of 22q deletions in four previously reported patients with conotruncal anomaly face syndrome.
    Pierpont JW; Erickson RP; Thompson FH; Yang JM
    Clin Genet; 1996 Dec; 50(6):545-7. PubMed ID: 9147896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closing time for CATCH22.
    Burn J
    J Med Genet; 1999 Oct; 36(10):737-8. PubMed ID: 10528851
    [No Abstract]   [Full Text] [Related]  

  • 19. CATCH 22: deletion of locus 22q11 in velocardiofacial syndrome, DiGeorge anomaly, and nonsyndromic conotruncal defects.
    Hou JW; Wang JK; Tsai WY; Chou CC; Wang TR
    J Formos Med Assoc; 1997 Jun; 96(6):419-23. PubMed ID: 9216164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Avoiding perils and pitfalls in velocardiofacial syndrome: an otolaryngologist's perspective.
    Cable BB; Mair EA
    Ear Nose Throat J; 2003 Jan; 82(1):56-60. PubMed ID: 12610907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.